Sanofi SASanofi SASanofi SA

Sanofi SA

No trades
See on Supercharts

Key facts today


Thermo Fisher Scientific has acquired Sanofi's Ridgefield, New Jersey site to boost U.S. manufacturing for pharma and biotech, while still producing therapies for Sanofi.
Analyze the impactAnalyze the impact
Market capitalization
‪103.26 B‬EUR
7.39EUR
‪5.56 B‬EUR
‪41.08 B‬EUR
‪1.11 B‬
Beta (1Y)
0.73
Employees (FY)
‪84.59 K‬
Change (1Y)
‪−3.41 K‬ −3.87%
Revenue / Employee (1Y)
‪485.67 K‬EUR
Net income / Employee (1Y)
‪64.97 K‬EUR

About Sanofi SA


CEO
Paul Hudson
Website
Headquarters
Paris
Founded
1994
ISIN
FR0000120578
FIGI
BBG000F5DZZ1
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.

Check out other big names from the same industry as 1SAN.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
K
KDMN5364231
Kadmon Holdings, Inc. 3.625% 15-FEB-2027
Yield to maturity
Maturity date
Feb 15, 2027
FR1350511
Sanofi 1.5% 01-APR-2030
Yield to maturity
Maturity date
Apr 1, 2030
FR14009KQ
Sanofi 1.25% 06-APR-2029
Yield to maturity
Maturity date
Apr 6, 2029
US801060AD6
Sanofi SA 3.625% 19-JUN-2028
Yield to maturity
Maturity date
Jun 19, 2028
FR1332435
Sanofi SA 1.375% 21-MAR-2030
Yield to maturity
Maturity date
Mar 21, 2030
FR1340985
Sanofi 1.25% 21-MAR-2034
Yield to maturity
Maturity date
Mar 21, 2034
FR14010MR
Sanofi SA 3.0% 23-JUN-2032
Yield to maturity
Maturity date
Jun 23, 2032
FR1340984
Sanofi 0.875% 21-MAR-2029
Yield to maturity
Maturity date
Mar 21, 2029
FR1400Y1H
Sanofi SA FRN 11-MAR-2027
Yield to maturity
Maturity date
Mar 11, 2027
FR1314400
Sanofi 1.125% 05-APR-2028
Yield to maturity
Maturity date
Apr 5, 2028
FR1332434
Sanofi SA 1.0% 21-MAR-2026
Yield to maturity
Maturity date
Mar 21, 2026

See all 1SAN bonds 

Frequently Asked Questions


The current price of 1SAN is 86.01 EUR — it has increased by 0.14% in the past 24 hours. Watch Sanofi SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange Sanofi SA stocks are traded under the ticker 1SAN.
1SAN stock has fallen by −9.05% compared to the previous week, the month change is a 9.32% rise, over the last year Sanofi SA has showed a −17.57% decrease.
We've gathered analysts' opinions on Sanofi SA future price: according to them, 1SAN price has a max estimate of 124.80 EUR and a min estimate of 92.00 EUR. Watch 1SAN chart and read a more detailed Sanofi SA stock forecast: see what analysts think of Sanofi SA and suggest that you do with its stocks.
1SAN reached its all-time high on Mar 24, 2025 with the price of 111.00 EUR, and its all-time low was 37.70 EUR and was reached on Oct 10, 2008. View more price dynamics on 1SAN chart.
See other stocks reaching their highest and lowest prices.
1SAN stock is 4.03% volatile and has beta coefficient of 0.73. Track Sanofi SA stock price on the chart and check out the list of the most volatile stocks — is Sanofi SA there?
Today Sanofi SA has the market capitalization of ‪102.83 B‬, it has decreased by −2.05% over the last week.
Yes, you can track Sanofi SA financials in yearly and quarterly reports right on TradingView.
1SAN net income for the last half-year is ‪5.81 B‬ EUR, while the previous report showed ‪3.31 B‬ EUR of net income which accounts for 75.38% change. Track more Sanofi SA financial stats to get the full picture.
Yes, 1SAN dividends are paid annually. The last dividend per share was 3.92 EUR. As of today, Dividend Yield (TTM)% is 4.64%. Tracking Sanofi SA dividends might help you take more informed decisions.
Sanofi SA dividend yield was 4.18% in 2024, and payout ratio reached 88.23%. The year before the numbers were 4.19% and 87.16% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 3, 2025, the company has ‪84.59 K‬ employees. See our rating of the largest employees — is Sanofi SA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Sanofi SA EBITDA is ‪13.86 B‬ EUR, and current EBITDA margin is 31.98%. See more stats in Sanofi SA financial statements.
Like other stocks, 1SAN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sanofi SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Sanofi SA technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Sanofi SA stock shows the sell signal. See more of Sanofi SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.